Oil prices hold sharp losses with focus on secondary India tariffs
Investing.com - Barclays (LON:BARC) has upgraded Givaudan SA (SIX:GIVN) stock rating from Underweight to Equalweight while raising its price target to CHF4,000.00 from CHF3,800.00.
The upgrade reflects Barclays’ increased optimism about Givaudan’s Taste & Wellness division’s top-line growth prospects over the next five years. The firm believes this growth could support a modest increase in the company’s mid-term growth targets, which Givaudan is scheduled to present on August 27.
Barclays identified Givaudan as one of the companies best positioned to capitalize on accelerated reformulation trends toward natural ingredient solutions in the U.S. market over the coming years, citing the breadth of its natural solutions portfolio, scale, and strong customer relationships.
Despite the upgrade, Barclays maintained a measured stance, noting that Givaudan’s premium valuation limits its enthusiasm for the stock. The firm also expressed concern that potential moderation in Fragrance division growth over the next five years could constrain margin expansion opportunities.
Givaudan, which trades in the U.S. as (OTC:GVDNY), is one of the world’s largest manufacturers of flavors, fragrances, and active cosmetic ingredients.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.